摘要
目的:观察奥施康定治疗儿童癌痛临床疗效及安全性。方法:应用奥施康定治疗45例重度癌痛患儿,奥施康定初始剂量10mg/12h。每24h根据病情、镇痛效果进行剂量滴定一次,24h如疼痛分数下降不至3分以下(含3分),且每日突破性疼痛大于2次,则第二天加前1天剂量的25%-50%。结果:45例患者奥施康定用药最小剂量10mg/12h,最大剂量60mg/12h,中位数40mg/12h。治疗后疼痛控制总有效率为100%。主要不良反应为便秘、恶心、头昏、嗜睡、皮肤瘙痒,均为轻中度,无重度不良反应发生。结论:奥施康定对儿童癌痛镇痛效果好、毒副作用小、疗效确切、安全性高。
Objective: To observe the therapeutic effect and safety of Oxycontin in the treatment of 45 pediatric cases with severe cancer pain. Methods: 45 pediatric cases with severe cancer pain were treated with Oxycontin. Oxycontin was administered at an initial does of 10 mg /12 h,and titrated every 24 hours according to the pain control and the adverse reactions. The second day,if score of pain decreased no less than 3( including 3 scores) and breakthrough pains are greater than 2 times,the total daily Oxycontin dose were increased by 25% to 50% of the before dose. Results: Among the 45 pediatric cases with severe cancer pain,the maximum dose of oxycontin was 10 mg /12 h,the minimum was 60 mg /12 h and the media was 40 mg /12 h. Total pain relief rate was 100%. The main adverse reactions were constipation,nausea,dizziness,somnolence,itch of skin,which were mild or moderate adverse effects,no severe adverse effect. Conclusion: Oxycontin showed good therapeutic effect in the treatment of pediatric cases with severe cancer pain,with mild adverse reactions,and high clinical safety.
出处
《现代肿瘤医学》
CAS
2015年第15期2204-2205,共2页
Journal of Modern Oncology
关键词
奥施康定
儿童
癌痛
Oxycontin
pediatric
cancer pain